Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer
Clinical trial NCT01186991 · COMPLETED
Trial details
- NCT number
- NCT01186991
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2016-03-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.